Welcome to our dedicated page for Bioceres Crop Solutions SEC filings (Ticker: BIOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bioceres Crop Solutions Corp. filings document a foreign private issuer reporting through Form 6-K as a Form 20-F filer, with interim results, press releases and XBRL-tagged financial data prepared under IFRS. The disclosures cover revenue and margin trends by crop protection, seed and integrated products, and crop nutrition, along with currency risk, property and equipment, debt securities, bank borrowings, subsidiaries, joint ventures and associates.
The filing record also includes annual general meeting proxy materials, Nasdaq minimum bid-price correspondence, and material-event reports involving convertible and non-convertible note purchase agreements, acceleration notices, collateral matters and Pro Farm-related proceedings. Certain Form 6-K reports are incorporated by reference into Form F-3 and Form S-8 registration statements, linking current reports to the company's securities registration disclosures.
Bioceres Crop Solutions Corp. General Counsel Roque Jose Augusto has filed an initial Form 3 showing his equity holdings in the company. He directly owns 667 Ordinary Shares and holds stock options covering 40,000 Ordinary Shares at an exercise price of $10.47 per share. These options become exercisable on August 21, 2025 and expire on August 21, 2028. The filing reports existing positions and does not show any recent share purchases or sales.
Bioceres Crop Solutions Corp. CFO Ezequiel Simmermacher has filed an initial Form 3, which is the required statement of beneficial ownership for company insiders. The filing reports no transactions, meaning there are currently no disclosed purchases, sales, or derivative exercises associated with this insider in this report.
Agriculture Investment Group Corp. and Granosur Holding Limited filed an amended Schedule 13D reporting a reduced stake in Bioceres Crop Solutions Corp. They now beneficially own 5,776,807 Ordinary Shares, representing 9.05% of the company, based on 63,815,891 shares outstanding as of December 31, 2025.
The change reflects share sales in Bioceres. In connection with the transaction, AIGC sold 1,077,973 shares and Granosur sold 23,193 shares. Item 5 details open-market sales between March 13 and March 20, 2026 at average prices between $0.36 and $0.53 per share, with each day’s aggregate gross proceeds disclosed.
Bioceres Crop Solutions Corp. reported that it received a Nasdaq bid-price deficiency notice after its ordinary shares closed below $1.00 for 30 consecutive business days, breaching Nasdaq Listing Rule 5450(a)(1). The notice does not immediately affect the Nasdaq Global Select Market listing, and the BIOX shares continue to trade.
Bioceres has 180 calendar days, until September 14, 2026, to regain compliance by having a closing bid price at or above $1.00 for at least ten consecutive business days. If it fails to do so, the company may seek an additional 180-day period but could ultimately face delisting if it cannot meet Nasdaq’s requirements. Management states it is committed to regaining compliance and will monitor the share price and consider available options.
Bioceres Crop Solutions describes a challenging first half of fiscal 2026. The continuing business in crop protection, nutrition, and seeds maintained a consolidated gross margin of 40% year-to-date, in line with the prior year, despite weak Argentine farmer economics and tight credit conditions.
The company records an impairment loss of $179 million after a foreclosure auction of Pro Farm collateral assets, where noteholders bid $15 million. Pro Farm operations are now classified as discontinued, while core Argentine and technology-platform activities continue.
Bioceres’ financial statements disclose substantial doubt about its ability to continue as a going concern. Management is pursuing refinancing with local lenders, potential asset disposals, and new long-term financing, and is preparing a three-year plan focused on profitability, cash generation, and a sustainable capital structure.
Bioceres Crop Solutions reported unaudited results showing severe financial stress for the six months ended December 31, 2025. Revenue from continuing operations was $142.6M, down from $182.3M a year earlier, while the period’s net loss widened to $189.9M.
The loss was driven mainly by a $179.0M impairment tied to assets subject to foreclosure under its Secured notes. Net assets subject to foreclosure were $194.0M, versus consideration offered by noteholder-affiliated entities of $15.0M, leading to recognition of a discontinued operation.
Total assets fell to $560.4M from $763.6M, and total equity declined to $106.6M from $295.2M. All $104.4M of Secured notes and the $20M Rabobank facility are classified as current after covenant breaches, and management highlights “material uncertainty” that raises substantial doubt about the Group’s ability to continue as a going concern.
Bioceres Crop Solutions Corp. received an Amendment No. 3 to a Schedule 13D from Agriculture Investment Group Corp. (AIGC) and Granosur Holding Limited, both based in the British Virgin Islands. AIGC now beneficially owns 6,877,973 ordinary shares, representing 10.8% of Bioceres’ outstanding ordinary shares as of September 30, 2025.
The filing reports that AIGC sold an aggregate of 2,235,197 shares of Bioceres in a series of open market transactions between March 2 and March 12, 2026, at prices ranging from $0.45 to $0.58 per share. After these sales, AIGC holds 1,077,973 shares directly and 5,800,000 shares are held by its wholly owned subsidiary Granosur. The reporting persons state they have no current specific plans for major corporate actions but may reconsider their position over time.
Agriculture Investment Group Corp. (AIGC) and Granosur Holding Limited filed Amendment No. 2 to their Schedule 13D on Bioceres Crop Solutions Corp., reporting a reduced beneficial ownership position following open market share sales.
AIGC sold an aggregate of 673,225 ordinary shares of Bioceres in February 2026 at average prices between $0.55 and $0.60 per share, leaving the reporting persons with 9,113,170 shares, or 14.36% of Bioceres’ ordinary shares, based on 63,478,813 shares outstanding as of September 30, 2025. Of this amount, 3,313,170 shares are held by AIGC and 5,800,000 shares are held by Granosur, with AIGC as the ultimate beneficial owner.
Bioceres Crop Solutions Corp. received an updated ownership filing from the Draco group of investors. In this Amendment No. 2 to a Schedule 13G, DRACO I SPC LTD, DRACO Capital Investment Management Company Ltd, and DRACO I EVENT OPPORTUNITY SEGREGATED PORTFOLIO each report beneficial ownership of 0 ordinary shares, or 0.0% of Bioceres’ outstanding ordinary shares.
The Draco entities state they have no sole or shared power to vote or dispose of any Bioceres shares and confirm they now own 5 percent or less of the class. They also certify that any securities previously held were not acquired to change or influence control of Bioceres.
Agriculture Investment Group Corp. (AIGC) and Granosur Holding Limited have amended their beneficial ownership report for Bioceres Crop Solutions Corp. They now beneficially own 9,786,395 ordinary shares, equal to 15.42% of Bioceres, based on 63,478,813 shares outstanding as of September 30, 2025.
The holdings consist of 3,986,395 shares held by AIGC and 5,800,000 shares held by Granosur, with shared voting and dispositive power over these positions. AIGC sold an aggregate 908,274 shares in open‑market transactions in January and early February 2026 at average prices between $0.60 and $1.23 per share, reducing its stake. The reporting persons state they have no current specific plans for corporate actions regarding Bioceres but may reconsider their position over time.